SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '3n3z'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XLX_A_CIOA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	5 / 12	HIS A 252 HIS A 296 MET A 365 ASN A 405 GLN A 453	None None None IBM A 1 (-3.5A) IBM A 1 (-3.5A)	0.83A	1xlxA-3n3zA: 41.1	1xlxA-3n3zA: 30.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XLX_A_CIOA101_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	5 / 12	HIS A 252 HIS A 296 MET A 365 GLN A 453 PHE A 456	None None None IBM A 1 (-3.5A) IBM A 1 (-3.4A)	0.63A	1xlxA-3n3zA: 41.1	1xlxA-3n3zA: 30.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XLX_B_CIOB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	5 / 12	HIS A 252 HIS A 296 MET A 365 GLN A 453 PHE A 456	None None None IBM A 1 (-3.5A) IBM A 1 (-3.4A)	0.57A	1xlxB-3n3zA: 40.8	1xlxB-3n3zA: 30.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XLX_B_CIOB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	5 / 12	HIS A 292 MET A 365 PHE A 251 GLN A 453 PHE A 456	ZN A 507 (-3.5A) None IBM A 1 ( 4.9A) IBM A 1 (-3.5A) IBM A 1 (-3.4A)	1.30A	1xlxB-3n3zA: 40.8	1xlxB-3n3zA: 30.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOM_A_CIOA603_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	5 / 12	HIS A 252 MET A 365 ASP A 402 GLN A 453 PHE A 456	None None ZN A 507 (-2.9A) IBM A 1 (-3.5A) IBM A 1 (-3.4A)	0.58A	1xomA-3n3zA: 41.3	1xomA-3n3zA: 30.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOQ_A_ROFA502_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	3 / 3	ASN A 405 TRP A 416 GLN A 453	IBM A 1 (-3.5A) None IBM A 1 (-3.5A)	0.86A	1xoqA-3n3zA: 41.3	1xoqA-3n3zA: 30.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOQ_B_ROFB501_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	3 / 3	MET A 365 ASN A 405 GLN A 453	None IBM A 1 (-3.5A) IBM A 1 (-3.5A)	0.88A	1xoqB-3n3zA: 41.3	1xoqB-3n3zA: 30.60
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOS_A_VIAA1_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	5 / 12	HIS A 252 MET A 365 ASP A 402 GLN A 453 PHE A 456	None None ZN A 507 (-2.9A) IBM A 1 (-3.5A) IBM A 1 (-3.4A)	0.51A	1xosA-3n3zA: 41.3	1xosA-3n3zA: 30.69
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	1XOT_B_VDNB102_1 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	5 / 12	HIS A 252 MET A 365 ASN A 405 GLN A 453 PHE A 456	None None IBM A 1 (-3.5A) IBM A 1 (-3.5A) IBM A 1 (-3.4A)	0.80A	1xotB-3n3zA: 41.2	1xotB-3n3zA: 30.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2OZ7_A_CA4A1_2 (ANDROGEN RECEPTOR)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	4 / 6	LEU A 205 MET A 263 MET A 218 LEU A 196	None	1.38A	2oz7A-3n3zA: undetectable	2oz7A-3n3zA: 21.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2PRG_B_BRLB2_1 (PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	5 / 12	HIS A 220 LEU A 222 VAL A 268 MET A 286 LEU A 239	None	1.30A	2prgB-3n3zA: undetectable	2prgB-3n3zA: 20.11
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XAD_E_GCSE710_1 (N-ACYL GLM PEUDO-TEICOPLANIN DEACETYLASE TEICOPLANIN)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	4 / 8	HIS A 292 ASP A 402 ILE A 403 HIS A 256	ZN A 507 (-3.5A) ZN A 507 (-2.9A) IBM A 1 (-4.3A) ZN A 507 (-3.8A)	0.99A	2xadA-3n3zA: undetectable	2xadA-3n3zA: 23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XAD_F_GCSF710_1 (N-ACYL GLM PEUDO-TEICOPLANIN DEACETYLASE TEICOPLANIN)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	4 / 8	HIS A 292 ASP A 402 ILE A 403 HIS A 256	ZN A 507 (-3.5A) ZN A 507 (-2.9A) IBM A 1 (-4.3A) ZN A 507 (-3.8A)	1.02A	2xadB-3n3zA: undetectable	2xadB-3n3zA: 23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XAD_G_GCSG710_1 (N-ACYL GLM PEUDO-TEICOPLANIN DEACETYLASE TEICOPLANIN)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	4 / 8	HIS A 292 ASP A 402 ILE A 403 HIS A 256	ZN A 507 (-3.5A) ZN A 507 (-2.9A) IBM A 1 (-4.3A) ZN A 507 (-3.8A)	1.02A	2xadC-3n3zA: undetectable	2xadC-3n3zA: 23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2XAD_H_GCSH710_1 (N-ACYL GLM PEUDO-TEICOPLANIN DEACETYLASE TEICOPLANIN)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	4 / 8	HIS A 292 ASP A 402 ILE A 403 HIS A 256	ZN A 507 (-3.5A) ZN A 507 (-2.9A) IBM A 1 (-4.3A) ZN A 507 (-3.8A)	1.01A	2xadD-3n3zA: undetectable	2xadD-3n3zA: 23.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASN_P_CHDP1271_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	4 / 7	LEU A 483 PHE A 465 LEU A 461 PHE A 456	None None None IBM A 1 (-3.4A)	1.00A	3asnP-3n3zA: 3.3 3asnW-3n3zA: undetectable	3asnP-3n3zA: 21.17 3asnW-3n3zA: 9.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3ASO_P_CHDP1271_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	4 / 7	LEU A 483 PHE A 465 LEU A 461 PHE A 456	None None None IBM A 1 (-3.4A)	1.01A	3asoP-3n3zA: 3.2 3asoW-3n3zA: undetectable	3asoP-3n3zA: 21.17 3asoW-3n3zA: 9.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CR4_X_PNTX101_0 (PROTEIN S100-B)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	3 / 3	CYH A 241 HIS A 243 PHE A 240	None	1.10A	3cr4X-3n3zA: 0.0	3cr4X-3n3zA: 17.29
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_B_ROFB902_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	5 / 12	HIS A 252 MET A 365 ASP A 402 TRP A 416 PHE A 456	None None ZN A 507 (-2.9A) None IBM A 1 (-3.4A)	0.60A	3g4lB-3n3zA: 41.0	3g4lB-3n3zA: 30.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_C_ROFC903_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	5 / 12	HIS A 252 MET A 365 ASP A 402 ASN A 405 TRP A 416	None None ZN A 507 (-2.9A) IBM A 1 (-3.5A) None	0.85A	3g4lC-3n3zA: 41.1	3g4lC-3n3zA: 30.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3G4L_D_ROFD904_0 (CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	5 / 12	HIS A 252 MET A 365 ASP A 402 TRP A 416 GLN A 453	None None ZN A 507 (-2.9A) None IBM A 1 (-3.5A)	0.62A	3g4lD-3n3zA: 40.9	3g4lD-3n3zA: 30.18
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JWQ_C_VIAC901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	4 / 7	HIS A 252 GLN A 453 PHE A 456 VAL A 460	None IBM A 1 (-3.5A) IBM A 1 (-3.4A) None	0.57A	3jwqC-3n3zA: 41.8	3jwqC-3n3zA: 30.06
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3JWQ_C_VIAC901_1 (CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	4 / 7	HIS A 256 GLN A 453 PHE A 456 VAL A 460	ZN A 507 (-3.8A) IBM A 1 (-3.5A) IBM A 1 (-3.4A) None	0.83A	3jwqC-3n3zA: 41.8	3jwqC-3n3zA: 30.06
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3N58_A_ADNA500_2 (ADENOSYLHOMOCYSTEINA SE)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	4 / 5	GLN A 304 GLU A 322 THR A 363 HIS A 292	None None None ZN A 507 (-3.5A)	1.48A	3n58A-3n3zA: undetectable	3n58A-3n3zA: 20.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3V8V_A_SAMA801_0 (RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE L)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	5 / 12	MET A 479 SER A 486 VAL A 475 PRO A 199 LEU A 270	None	1.19A	3v8vA-3n3zA: undetectable	3v8vA-3n3zA: 17.47
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WFH_B_P2EB301_1 (MAB FAB H FRAGMENT MAB FAB L FRAGMENT)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	5 / 12	HIS A 325 VAL A 328 HIS A 296 PRO A 297 LEU A 311	MG A 508 ( 4.8A) None None None None	1.42A	3wfhA-3n3zA: undetectable 3wfhB-3n3zA: undetectable	3wfhA-3n3zA: 19.44 3wfhB-3n3zA: 19.44
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WG7_C_CHDC305_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	4 / 6	LEU A 483 PHE A 465 LEU A 461 PHE A 456	None None None IBM A 1 (-3.4A)	1.03A	3wg7C-3n3zA: 3.3 3wg7J-3n3zA: 1.4	3wg7C-3n3zA: 21.17 3wg7J-3n3zA: 9.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3WG7_P_CHDP306_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	4 / 6	LEU A 483 PHE A 465 LEU A 461 PHE A 456	None None None IBM A 1 (-3.4A)	0.97A	3wg7P-3n3zA: 3.2 3wg7W-3n3zA: undetectable	3wg7P-3n3zA: 21.17 3wg7W-3n3zA: 9.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OJ4_A_DIFA501_1 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	5 / 8	CYH A 401 SER A 404 VAL A 468 ILE A 396 MET A 267	None	1.43A	4oj4A-3n3zA: 2.1	4oj4A-3n3zA: 19.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4ZN7_A_DESA601_1 (ESTROGEN RECEPTOR)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	5 / 12	ALA A 406 LEU A 420 MET A 365 HIS A 368 LEU A 483	IBM A 1 ( 4.7A) IBM A 1 (-4.8A) None None None	1.08A	4zn7A-3n3zA: undetectable	4zn7A-3n3zA: 19.76
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5X19_C_CHDC304_0 (CYTOCHROME C OXIDASE SUBUNIT 3 CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	4 / 5	LEU A 483 PHE A 465 LEU A 461 PHE A 456	None None None IBM A 1 (-3.4A)	1.02A	5x19C-3n3zA: undetectable 5x19J-3n3zA: undetectable	5x19C-3n3zA: 21.17 5x19J-3n3zA: 9.82
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	6GNE_B_ACRB602_2 (-)	3n3z	HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A (Homo sapiens)	4 / 8	HIS A 252 TYR A 299 GLU A 422 CYH A 419	None	1.30A	6gneB-3n3zA: undetectable	6gneB-3n3zA: 22.33

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1XLX_A_CIOA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",5,"HIS A 252;HIS A 296;MET A 365;ASN A 405;GLN A 453","None;None;None;IBM A   1 (-3.5A);IBM A   1 (-3.5A)","0.83A","1xlxA-3n3zA:41.1","1xlxA-3n3zA:30.69"],["1XLX_A_CIOA101_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",5,"HIS A 252;HIS A 296;MET A 365;GLN A 453;PHE A 456","None;None;None;IBM A   1 (-3.5A);IBM A   1 (-3.4A)","0.63A","1xlxA-3n3zA:41.1","1xlxA-3n3zA:30.69"],["1XLX_B_CIOB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",5,"HIS A 252;HIS A 296;MET A 365;GLN A 453;PHE A 456","None;None;None;IBM A   1 (-3.5A);IBM A   1 (-3.4A)","0.57A","1xlxB-3n3zA:40.8","1xlxB-3n3zA:30.69"],["1XLX_B_CIOB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",5,"HIS A 292;MET A 365;PHE A 251;GLN A 453;PHE A 456"," ZN A 507 (-3.5A);None;IBM A   1 ( 4.9A);IBM A   1 (-3.5A);IBM A   1 (-3.4A)","1.30A","1xlxB-3n3zA:40.8","1xlxB-3n3zA:30.69"],["1XOM_A_CIOA603_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",5,"HIS A 252;MET A 365;ASP A 402;GLN A 453;PHE A 456","None;None; ZN A 507 (-2.9A);IBM A   1 (-3.5A);IBM A   1 (-3.4A)","0.58A","1xomA-3n3zA:41.3","1xomA-3n3zA:30.60"],["1XOQ_A_ROFA502_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",3,"ASN A 405;TRP A 416;GLN A 453","IBM A   1 (-3.5A);None;IBM A   1 (-3.5A)","0.86A","1xoqA-3n3zA:41.3","1xoqA-3n3zA:30.60"],["1XOQ_B_ROFB501_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",3,"MET A 365;ASN A 405;GLN A 453","None;IBM A   1 (-3.5A);IBM A   1 (-3.5A)","0.88A","1xoqB-3n3zA:41.3","1xoqB-3n3zA:30.60"],["1XOS_A_VIAA1_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",5,"HIS A 252;MET A 365;ASP A 402;GLN A 453;PHE A 456","None;None; ZN A 507 (-2.9A);IBM A   1 (-3.5A);IBM A   1 (-3.4A)","0.51A","1xosA-3n3zA:41.3","1xosA-3n3zA:30.69"],["1XOT_B_VDNB102_1","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4B","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",5,"HIS A 252;MET A 365;ASN A 405;GLN A 453;PHE A 456","None;None;IBM A   1 (-3.5A);IBM A   1 (-3.5A);IBM A   1 (-3.4A)","0.80A","1xotB-3n3zA:41.2","1xotB-3n3zA:30.69"],["2OZ7_A_CA4A1_2","ANDROGEN RECEPTOR","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",4,"LEU A 205;MET A 263;MET A 218;LEU A 196","None","1.38A","2oz7A-3n3zA:undetectable","2oz7A-3n3zA:21.45"],["2PRG_B_BRLB2_1","PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",5,"HIS A 220;LEU A 222;VAL A 268;MET A 286;LEU A 239","None","1.30A","2prgB-3n3zA:undetectable","2prgB-3n3zA:20.11"],["2XAD_E_GCSE710_1","N-ACYL GLM PEUDO-TEICOPLANIN DEACETYLASE;TEICOPLANIN","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",4,"HIS A 292;ASP A 402;ILE A 403;HIS A 256"," ZN A 507 (-3.5A); ZN A 507 (-2.9A);IBM A   1 (-4.3A); ZN A 507 (-3.8A)","0.99A","2xadA-3n3zA:undetectable","2xadA-3n3zA:23.44"],["2XAD_F_GCSF710_1","N-ACYL GLM PEUDO-TEICOPLANIN DEACETYLASE;TEICOPLANIN","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",4,"HIS A 292;ASP A 402;ILE A 403;HIS A 256"," ZN A 507 (-3.5A); ZN A 507 (-2.9A);IBM A   1 (-4.3A); ZN A 507 (-3.8A)","1.02A","2xadB-3n3zA:undetectable","2xadB-3n3zA:23.44"],["2XAD_G_GCSG710_1","N-ACYL GLM PEUDO-TEICOPLANIN DEACETYLASE;TEICOPLANIN","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",4,"HIS A 292;ASP A 402;ILE A 403;HIS A 256"," ZN A 507 (-3.5A); ZN A 507 (-2.9A);IBM A   1 (-4.3A); ZN A 507 (-3.8A)","1.02A","2xadC-3n3zA:undetectable","2xadC-3n3zA:23.44"],["2XAD_H_GCSH710_1","N-ACYL GLM PEUDO-TEICOPLANIN DEACETYLASE;TEICOPLANIN","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",4,"HIS A 292;ASP A 402;ILE A 403;HIS A 256"," ZN A 507 (-3.5A); ZN A 507 (-2.9A);IBM A   1 (-4.3A); ZN A 507 (-3.8A)","1.01A","2xadD-3n3zA:undetectable","2xadD-3n3zA:23.44"],["3ASN_P_CHDP1271_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",4,"LEU A 483;PHE A 465;LEU A 461;PHE A 456","None;None;None;IBM A   1 (-3.4A)","1.00A","3asnP-3n3zA:3.3;3asnW-3n3zA:undetectable","3asnP-3n3zA:21.17;3asnW-3n3zA:9.82"],["3ASO_P_CHDP1271_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",4,"LEU A 483;PHE A 465;LEU A 461;PHE A 456","None;None;None;IBM A   1 (-3.4A)","1.01A","3asoP-3n3zA:3.2;3asoW-3n3zA:undetectable","3asoP-3n3zA:21.17;3asoW-3n3zA:9.82"],["3CR4_X_PNTX101_0","PROTEIN S100-B","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",3,"CYH A 241;HIS A 243;PHE A 240","None","1.10A","3cr4X-3n3zA:0.0","3cr4X-3n3zA:17.29"],["3G4L_B_ROFB902_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",5,"HIS A 252;MET A 365;ASP A 402;TRP A 416;PHE A 456","None;None; ZN A 507 (-2.9A);None;IBM A   1 (-3.4A)","0.60A","3g4lB-3n3zA:41.0","3g4lB-3n3zA:30.18"],["3G4L_C_ROFC903_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",5,"HIS A 252;MET A 365;ASP A 402;ASN A 405;TRP A 416","None;None; ZN A 507 (-2.9A);IBM A   1 (-3.5A);None","0.85A","3g4lC-3n3zA:41.1","3g4lC-3n3zA:30.18"],["3G4L_D_ROFD904_0","CAMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 4D","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",5,"HIS A 252;MET A 365;ASP A 402;TRP A 416;GLN A 453","None;None; ZN A 507 (-2.9A);None;IBM A   1 (-3.5A)","0.62A","3g4lD-3n3zA:40.9","3g4lD-3n3zA:30.18"],["3JWQ_C_VIAC901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",4,"HIS A 252;GLN A 453;PHE A 456;VAL A 460","None;IBM A   1 (-3.5A);IBM A   1 (-3.4A);None","0.57A","3jwqC-3n3zA:41.8","3jwqC-3n3zA:30.06"],["3JWQ_C_VIAC901_1","CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE CATALYTIC DOMAIN, CONE CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE SUBUNIT ALPHA CHIMERA","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",4,"HIS A 256;GLN A 453;PHE A 456;VAL A 460"," ZN A 507 (-3.8A);IBM A   1 (-3.5A);IBM A   1 (-3.4A);None","0.83A","3jwqC-3n3zA:41.8","3jwqC-3n3zA:30.06"],["3N58_A_ADNA500_2","ADENOSYLHOMOCYSTEINASE","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",4,"GLN A 304;GLU A 322;THR A 363;HIS A 292","None;None;None; ZN A 507 (-3.5A)","1.48A","3n58A-3n3zA:undetectable","3n58A-3n3zA:20.50"],["3V8V_A_SAMA801_0","RIBOSOMAL RNA LARGE SUBUNIT METHYLTRANSFERASE L","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",5,"MET A 479;SER A 486;VAL A 475;PRO A 199;LEU A 270","None","1.19A","3v8vA-3n3zA:undetectable","3v8vA-3n3zA:17.47"],["3WFH_B_P2EB301_1","MAB FAB H FRAGMENT;MAB FAB L FRAGMENT","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",5,"HIS A 325;VAL A 328;HIS A 296;PRO A 297;LEU A 311"," MG A 508 ( 4.8A);None;None;None;None","1.42A","3wfhA-3n3zA:undetectable;3wfhB-3n3zA:undetectable","3wfhA-3n3zA:19.44;3wfhB-3n3zA:19.44"],["3WG7_C_CHDC305_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",4,"LEU A 483;PHE A 465;LEU A 461;PHE A 456","None;None;None;IBM A   1 (-3.4A)","1.03A","3wg7C-3n3zA:3.3;3wg7J-3n3zA:1.4","3wg7C-3n3zA:21.17;3wg7J-3n3zA:9.82"],["3WG7_P_CHDP306_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",4,"LEU A 483;PHE A 465;LEU A 461;PHE A 456","None;None;None;IBM A   1 (-3.4A)","0.97A","3wg7P-3n3zA:3.2;3wg7W-3n3zA:undetectable","3wg7P-3n3zA:21.17;3wg7W-3n3zA:9.82"],["4OJ4_A_DIFA501_1","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",5,"CYH A 401;SER A 404;VAL A 468;ILE A 396;MET A 267","None","1.43A","4oj4A-3n3zA:2.1","4oj4A-3n3zA:19.42"],["4ZN7_A_DESA601_1","ESTROGEN RECEPTOR","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",5,"ALA A 406;LEU A 420;MET A 365;HIS A 368;LEU A 483","IBM A   1 ( 4.7A);IBM A   1 (-4.8A);None;None;None","1.08A","4zn7A-3n3zA:undetectable","4zn7A-3n3zA:19.76"],["5X19_C_CHDC304_0","CYTOCHROME C OXIDASE SUBUNIT 3;CYTOCHROME C OXIDASE SUBUNIT 7A1, MITOCHONDRIAL","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",4,"LEU A 483;PHE A 465;LEU A 461;PHE A 456","None;None;None;IBM A   1 (-3.4A)","1.02A","5x19C-3n3zA:undetectable;5x19J-3n3zA:undetectable","5x19C-3n3zA:21.17;5x19J-3n3zA:9.82"],["6GNE_B_ACRB602_2","-","3n3z","HIGH AFFINITY CGMP-SPECIFIC 3',5'-CYCLIC PHOSPHODIESTERASE 9A","Homo sapiens",4,"HIS A 252;TYR A 299;GLU A 422;CYH A 419","None","1.30A","6gneB-3n3zA:undetectable","6gneB-3n3zA:22.33"]]